AAAAAA

   
Results: 1-25 | 26-32
Results: 1-25/32
STAGED ESTIMATION OF INTERNATIONAL DIFFUSION-MODELS - AN APPLICATION TO GLOBAL CELLULAR TELEPHONE ADOPTION
Authors: DEKIMPE MG PARKER PM SARVARY M
Citation: Mg. Dekimpe et al., STAGED ESTIMATION OF INTERNATIONAL DIFFUSION-MODELS - AN APPLICATION TO GLOBAL CELLULAR TELEPHONE ADOPTION, Technological forecasting & social change, 57(1-2), 1998, pp. 105-132
PROSTHETIC PATCH STABILIZATION OF CRURAL REPAIR IN ANTIREFLUX SURGERYIN CHILDREN
Authors: SIMPSON B RICKETTS RR PARKER PM
Citation: B. Simpson et al., PROSTHETIC PATCH STABILIZATION OF CRURAL REPAIR IN ANTIREFLUX SURGERYIN CHILDREN, The American surgeon, 64(1), 1998, pp. 67-69
COLLUSIVE CONDUCT IN DUOPOLIES - MULTIMARKET CONTACT AND CROSS-OWNERSHIP IN THE MOBILE TELEPHONE INDUSTRY
Authors: PARKER PM ROLLER LH
Citation: Pm. Parker et Lh. Roller, COLLUSIVE CONDUCT IN DUOPOLIES - MULTIMARKET CONTACT AND CROSS-OWNERSHIP IN THE MOBILE TELEPHONE INDUSTRY, The Rand journal of economics, 28(2), 1997, pp. 304-322
MARKETING INFORMATION - A COMPETITIVE ANALYSIS
Authors: SARVARY M PARKER PM
Citation: M. Sarvary et Pm. Parker, MARKETING INFORMATION - A COMPETITIVE ANALYSIS, Marketing science, 16(1), 1997, pp. 24-38
FORMULATING DYNAMIC STRATEGIES USING DECISION CALCULUS
Authors: PARKER PM SARVARY M
Citation: Pm. Parker et M. Sarvary, FORMULATING DYNAMIC STRATEGIES USING DECISION CALCULUS, European journal of operational research, 98(3), 1997, pp. 542-554
ALLOGENEIC MARROW TRANSPLANTATION - A CURATIVE OPTION FOR TREATMENT RELATED MYELODYSPLASIA (MDS)
Authors: ODONNELL M STEIN A SNYDER DS NADEMANEE A PARKER PM SMITH EP MOLINA A KASHYAP A MARGOLIN K SOMLO G FORMAN SJ
Citation: M. Odonnell et al., ALLOGENEIC MARROW TRANSPLANTATION - A CURATIVE OPTION FOR TREATMENT RELATED MYELODYSPLASIA (MDS), Blood, 90(10), 1997, pp. 1008-1008
A PROSPECTIVE RANDOMIZED TRIAL COMPARING CYCLOSPORINE-A AND PREDNISONE (CSA PSE) VERSUS CYCLOSPORINE-A, METHOTREXATE AND PREDNISONE (CSA/MTX/PSE) FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE - EFFECT ON CHRONIC GRAFT-VERSUS-HOST DISEASE AND LONG-TERM SURVIVAL/
Authors: ROSS M FORMAN SJ WONG RM SCHMIDT GM NILAND JC AMYLON MD DAGIS AC LONG GD NADEMANEE AP NEGRIN RS ODONNELL MR PARKER PM SMITH EP SYNDER DS STEIN AS BLUME KG CHAO NJ
Citation: M. Ross et al., A PROSPECTIVE RANDOMIZED TRIAL COMPARING CYCLOSPORINE-A AND PREDNISONE (CSA PSE) VERSUS CYCLOSPORINE-A, METHOTREXATE AND PREDNISONE (CSA/MTX/PSE) FOR THE PREVENTION OF ACUTE GRAFT-VERSUS-HOST DISEASE - EFFECT ON CHRONIC GRAFT-VERSUS-HOST DISEASE AND LONG-TERM SURVIVAL/, Blood, 90(10), 1997, pp. 2624-2624
IN-VIVO PURGING WITH HIGH-DOSE CYTARABINE FOLLOWED BY HIGH-DOSE CHEMORADIOTHERAPY AND REINFUSION OF UNPURGED BONE-MARROW FOR ADULT ACUTE MYELOGENOUS LEUKEMIA IN FIRST COMPLETE REMISSION
Authors: STEIN AS ODONNELL MR CHAI A SCHMIDT GM NADEMANEE A PARKER PM SMITH EP SNYDER DS MOLINA A STEPAN DE SPIELBERGER R SOMLO G MARGOLIN KA VORA N LIPSETT J LEE J NILAND J FORMAN SJ
Citation: As. Stein et al., IN-VIVO PURGING WITH HIGH-DOSE CYTARABINE FOLLOWED BY HIGH-DOSE CHEMORADIOTHERAPY AND REINFUSION OF UNPURGED BONE-MARROW FOR ADULT ACUTE MYELOGENOUS LEUKEMIA IN FIRST COMPLETE REMISSION, Journal of clinical oncology, 14(8), 1996, pp. 2206-2216
A CROSS-CULTURAL-STUDY OF INTERPERSONAL INFORMATION EXCHANGE
Authors: DAWAR N PARKER PM PRICE LJ
Citation: N. Dawar et al., A CROSS-CULTURAL-STUDY OF INTERPERSONAL INFORMATION EXCHANGE, Journal of international business studies, 27(3), 1996, pp. 497-516
IMPROVED CR RATE USING HIGH-DOSE MELPHALAN (HDM) PRE G-CSF-PRIMED DONOR LEUKOCYTE INFUSION (DLI) FOR 2ND ALLOGENEIC BMT - ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) PROPHYLAXIS IS NECESSARY FOR PATIENTS AT RISK FOR HYPERACUTE GVHD
Authors: PARKER PM KASHYAP A SPIELBERGER R SNIECZINSKI I CHOW W FUNG H MARGOLIN K MOLINA A NADEMANEE A ODONNELL M PLANAS I SMITH E SNYDER DS SOMLO G STEIN A FORMAN SJ
Citation: Pm. Parker et al., IMPROVED CR RATE USING HIGH-DOSE MELPHALAN (HDM) PRE G-CSF-PRIMED DONOR LEUKOCYTE INFUSION (DLI) FOR 2ND ALLOGENEIC BMT - ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) PROPHYLAXIS IS NECESSARY FOR PATIENTS AT RISK FOR HYPERACUTE GVHD, Blood, 88(10), 1996, pp. 3805-3805
HIGH-DOSE CHEMO RADIOTHERAPY (HDT) AND G-CSF PRIMED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN FOLLICULAR LOW-GRADE (FLGL) AND TRANSFORMED (TL) LYMPHOMA/
Authors: MOLINA A NADEMANEE A ODONNELL MR SNYDER DS STEIN AS PARKER PM SMITH EP LEE J PLANAS I KASHYAP A SPIELBERGER RT MARGOLIN K SOMLO G KAPOOR N CHOW W VORA N SNIECINSKI I NILAND J FORMAN SJ
Citation: A. Molina et al., HIGH-DOSE CHEMO RADIOTHERAPY (HDT) AND G-CSF PRIMED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN FOLLICULAR LOW-GRADE (FLGL) AND TRANSFORMED (TL) LYMPHOMA/, Blood, 88(10), 1996, pp. 472-472
BUSULFAN CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA/
Authors: ODONNELL MR LONG GD PARKER PM NILAND J NADEMANEE A AMYLON M CHAO N NEGRIN RS SCHMIDT GM SLOVAK ML SMITH EP SNYDER DS STEIN AS TRAWEEK T BLUME KG FORMAN SJ
Citation: Mr. Odonnell et al., BUSULFAN CYCLOPHOSPHAMIDE AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR MYELODYSPLASIA/, Journal of clinical oncology, 13(12), 1995, pp. 2973-2979
IMMUNE-MEDIATED MYELOPATHY AFTER ALLOGENEIC MARROW TRANSPLANTATION
Authors: OPENSHAW H SLATKIN NE PARKER PM FORMAN SJ
Citation: H. Openshaw et al., IMMUNE-MEDIATED MYELOPATHY AFTER ALLOGENEIC MARROW TRANSPLANTATION, Bone marrow transplantation, 15(4), 1995, pp. 633-636
SWEET LEMONS - ILLUSORY QUALITY, SELF-DECEIVERS, ADVERTISING, AND PRICE
Authors: PARKER PM
Citation: Pm. Parker, SWEET LEMONS - ILLUSORY QUALITY, SELF-DECEIVERS, ADVERTISING, AND PRICE, Journal of marketing research, 32(3), 1995, pp. 291-307
THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: PARKER PM CHAO N NADEMANEE A ODONNELL MR SCHMIDT GM SNYDER DS STEIN AS SMITH EP MOLINA A STEPAN DE KASHYAP A PLANAS I SPIELBERGER R SOMLO G MARGOLIN K ZWINGENBERGER K WILSMAN K NEGRIN RS LONG GD NILAND JC BLUME KG FORMAN SJ
Citation: Pm. Parker et al., THALIDOMIDE AS SALVAGE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 86(9), 1995, pp. 3604-3609
HIGH-DOSE CHEMOTHERAPY WITH OR WITHOUT TOTAL-BODY IRRADIATION FOLLOWED BY AUTOLOGOUS BONE-MARROW AND OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RELAPSED AND REFRACTORY HODGKINS-DISEASE - RESULTS IN 85 PATIENTS WITH ANALYSIS OF PROGNOSTIC FACTORS/
Authors: NADEMANEE A ODONNELL MR SNYDER DS SCHMIDT GM PARKER PM STEIN AS SMITH EP MOLINA A STEPAN DE SOMLO G MARGOLIN KA SNIECINSKI I DAGIS AC NILAND J PEZNER R FORMAN SJ
Citation: A. Nademanee et al., HIGH-DOSE CHEMOTHERAPY WITH OR WITHOUT TOTAL-BODY IRRADIATION FOLLOWED BY AUTOLOGOUS BONE-MARROW AND OR PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH RELAPSED AND REFRACTORY HODGKINS-DISEASE - RESULTS IN 85 PATIENTS WITH ANALYSIS OF PROGNOSTIC FACTORS/, Blood, 85(5), 1995, pp. 1381-1390
CENTRAL VENOUS CATHERIZATION DIFFERENT FOR CHILDREN
Authors: PARKER PM
Citation: Pm. Parker, CENTRAL VENOUS CATHERIZATION DIFFERENT FOR CHILDREN, The American surgeon, 61(12), 1995, pp. 1028-1028
HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA USING UNPRIMED AND GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS
Authors: NADEMANEE A SNIECINSKI I SCHMIDT GM DAGIS AC ODONNELL MR SNYDER DS PARKER PM STEIN AS SMITH EP MOLINA A STEPAN DE SOMLO G MARGOLIN KA WOO D NILAND JC FORMAN SJ
Citation: A. Nademanee et al., HIGH-DOSE THERAPY FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH HODGKINS-DISEASE AND NON-HODGKINS-LYMPHOMA USING UNPRIMED AND GRANULOCYTE-COLONY-STIMULATING FACTOR-MOBILIZED PERIPHERAL-BLOOD STEM-CELLS, Journal of clinical oncology, 12(10), 1994, pp. 2176-2186
AGGREGATE DIFFUSION FORECASTING MODELS IN MARKETING - A CRITICAL-REVIEW
Authors: PARKER PM
Citation: Pm. Parker, AGGREGATE DIFFUSION FORECASTING MODELS IN MARKETING - A CRITICAL-REVIEW, International journal of forecasting, 10(2), 1994, pp. 353-380
FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 94 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE
Authors: SNYDER DS NEGRIN RS ODONNELL MR CHAO NJ AMYLON MD LONG GD NADEMANEE AP STEIN AS PARKER PM SMITH EP SOMLO G MARGOLIN K MOLINA A STEPAN DE LIPSETT JA HOPPE RT SLOVAK ML NILAND JC DAGIS AC WONG RM FORMAN SJ BLUME KG
Citation: Ds. Snyder et al., FRACTIONATED TOTAL-BODY IRRADIATION AND HIGH-DOSE ETOPOSIDE AS A PREPARATORY REGIMEN FOR BONE-MARROW TRANSPLANTATION FOR 94 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE, Blood, 84(5), 1994, pp. 1672-1679
HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR REFRACTORY HODGKINS-DISEASE (HD) - RESULTS AND ANALYSIS OF PROGNOSTIC FACTORS
Authors: NADERMANEE A ODONNELL M SNYDER DS SCHMIDT GM PARKER PM STEIN AS SMITH EP MOLINA A STEPAN DE WONG KK SOMLO G MARGOLIN KA SNIECINSKI I DAGIS AC NILAND J PEZNER R FORMAN SJ
Citation: A. Nadermanee et al., HIGH-DOSE THERAPY AND AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR REFRACTORY HODGKINS-DISEASE (HD) - RESULTS AND ANALYSIS OF PROGNOSTIC FACTORS, Blood, 84(10), 1994, pp. 10000206-10000206
USE OF PREEMPTIVE GANCICLOVIR BASED SOLELY ON ASYMPTOMATIC PULMONARY CYTOMEGALOVIRUS-INFECTION IN MARROW TRANSPLANT RECIPIENTS - LONG-TERM FOLLOW-UP
Authors: ZAIA JA SCHMIDT GM CHAO NJ RIZK N NADEMANEE AP NILAND JC HORAK DA LEE J GALLEZHAWKINS G KUSNIERZGLAZ CR ODONNELL MR PARKER PM SNYDER DS SMITH EP STEIN A MOLINA A STEPAN D BLUME KG FORMAN SJ
Citation: Ja. Zaia et al., USE OF PREEMPTIVE GANCICLOVIR BASED SOLELY ON ASYMPTOMATIC PULMONARY CYTOMEGALOVIRUS-INFECTION IN MARROW TRANSPLANT RECIPIENTS - LONG-TERM FOLLOW-UP, Blood, 84(10), 1994, pp. 10000249-10000249
EXTRACORPOREAL PHOTOCHEMOTHERAPY (EP) FOR TREATMENT OF DRUG-RESISTANTGRAFT-VERSUS-HOST DISEASE (GVHD)
Authors: SMITH E SNIECINSKI I PARKER PM MOLINA A NADEMANEE A ODONNELL MR SNYDER DS STEIN A STEPAN DE FORMAN SJ
Citation: E. Smith et al., EXTRACORPOREAL PHOTOCHEMOTHERAPY (EP) FOR TREATMENT OF DRUG-RESISTANTGRAFT-VERSUS-HOST DISEASE (GVHD), Blood, 84(10), 1994, pp. 10000332-10000332
NEUTROPENIA IS A COMPLICATION OF THALIDOMIDE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE
Authors: PARKER PM NADEMANEE A ODONNELL MR SNYDER DS STEIN A SMITH E MOLINA A STEPAN DE CHAO N NILAND JC BLUME KG FORMAN SJ
Citation: Pm. Parker et al., NEUTROPENIA IS A COMPLICATION OF THALIDOMIDE THERAPY FOR CHRONIC GRAFT-VERSUS-HOST DISEASE, Blood, 84(10), 1994, pp. 10000335-10000335
A SCALE-INVARIANT TREATMENT FOR RECURSIVE PATH MODELS
Authors: MCDONALD RP PARKER PM ISHIZUKA T
Citation: Rp. Mcdonald et al., A SCALE-INVARIANT TREATMENT FOR RECURSIVE PATH MODELS, Psychometrika, 58(3), 1993, pp. 431-443
Risultati: 1-25 | 26-32